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Abstract 
Screening for Generalized Anxiety Disorder Using a Self-Report Questionnaire: Validity 
of the Worry and Anxiety Questionnaire II 
Amelie Doucet 
The Worry and Anxiety Questionnaire (WAQ) is an 11-item self-report screening 
questionnaire developed to measure the DSM-IV diagnostic criteria for Generalized 
Anxiety Disorder (GAD). The purpose of this research was to revise the WAQ and 
conduct a preliminary investigation of the psychometric properties of the modified 
questionnaire in an English-speaking, non-clinical sample. The modification process 
included adding a definition for worry, simplifying the Likert scale qualifiers and 
consulting with experts in the field of anxiety disorders. There was evidence of 
sensitivity, specificity as well as convergent and discriminant validity; scores on the 
WAQ-II were more strongly associated with scores on a measure of worry than with 
scores on measures of other anxiety disorders, depression and hypochondriasis. In 
addition, there was evidence of test-retest reliability over a three-week period. The WAQ-
II's usefulness in research and clinical practice is discussed. 
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Generalized Anxiety Disorder (GAD) is characterized by chronic, uncontrollable, 
and excessive worry about a variety of everyday subjects. It is among the most common 
anxiety disorders and the second most common mental health problem found in primary 
care facilities (Wittchen et al., 2002). In the general population, the 12-month prevalence 
of GAD is between 2% and 4%, and the lifetime prevalence is between 4% and 7% 
(Hunt, Issakidis, & Andrews, 2002; Kessler et al., 1997). People with GAD are more 
likely to report a decreased sense of well being, and dissatisfaction with their family life 
and with "main activities" such as employment (Stein & Heimberg, 2004). They often 
have difficulty concentrating at work, suffer from exhaustion, and have physical 
symptoms ranging from gastrointestinal upset to muscle tension and headaches (Dugas & 
Robichaud, 2007; Kessler & Wittchen, 2002). 
Yet, despite its high frequency and impact, GAD is one of the most challenging 
mental health problems to properly diagnose. One reason that GAD is difficult to identify 
relates to the fact that worry and anxiety are universal experiences. Consequently, it can 
be difficult to determine when worry becomes "excessive" or "unrealistic" (Francis & 
Dugas, 2004). As a result, symptoms may be minimized, ignored or dismissed by family, 
friends and GAD sufferers. In addition, GAD does not have the obvious behavioural 
manifestations seen in other anxiety disorders. For example, people with GAD do not 
engage in the fear-driven compulsions seen in obsessive-compulsive disorder or the 
panic-driven avoidance of places and events observed in agoraphobia (Dugas & 
Robichaud, 2007). As a result, people with GAD often do not seek help from mental 
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health professionals for their worry and anxiety (Young, Klap, Sherbourne, & Wells, 
2001). 
GAD sufferers do, however, consult first-line medical professionals. According to 
recent research, people with GAD make twice as many visits to their primary care 
physician as do non-anxious individuals with similar physical conditions (Kessler & 
Wittchen, 2002). It is unusual for anxious or depressed individuals to consult a mental 
health professional without first seeing their primary care physician for advice and 
referral. Weiller, Bisserbe, Maier and Lecrubier (1998) found that only 1.9% of American 
adults with clinical levels of anxiety and/or depression consulted a mental health 
professional without first seeing a general medical practitioner. 
Unfortunately, of the many clinically-anxious patients who are seen in primary 
care, the vast majority are not referred for specialized psychological services because 
their anxious symptoms go unrecognized. In a study of 539 primary care patients with at 
least one anxiety disorder, half of the patients remained untreated for anxiety (Weisberg, 
Dyck, Culpepper, & Keller, 2007). In addition, because GAD sufferers tend to attribute 
their symptoms to physical illness, they are often referred to specialists other than 
psychologists or psychiatrists. For example, one study found that twice as many people 
with GAD were treated by a gastroenterologist than by a psychiatrist (Kennedy & 
Schwab, 1997). In addition, a survey of 154 GAD patients revealed that 50% had 
consulted with a cardiologist (Logue, Thomas, Barbee, & Hoehn-Saric, 1993). Given that 
individuals with chronic forms of clinical anxiety such as GAD may be particularly at 
risk of being misdiagnosed in primary care, there is an urgent need to develop and 
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validate clinically-usefUl screening instruments that can be used by general practitioners 
to conduct a preliminary assessment of GAD. 
Considering that self-report questionnaires can be brief, inexpensive, easily 
administered, simply scored, and highly informative, they are arguably the ideal choice 
for screening difficult to identify conditions such as GAD in primary care. Simply stated, 
the most clinically-useful way to screen for GAD may very well be to use a self-report 
questionnaire. 
Several practical and theoretical issues must be considered when choosing or 
developing a screening measure for GAD. The measure should be simple and easy to 
understand, score and interpret. In addition, the measure should also have sound 
psychometric properties; in particular, it should show evidence of sensitivity and 
specificity in clinical populations. In addition, the measure should ideally use continuous 
rating scales, which are typically more reliable and informative than dichotomous rating 
scales. 
Two self-report measures frequently used to assess GAD meet many of the 
aforementioned criteria. The Perm State Worry Questionnaire (PSWQ; Meyer, Miller, 
Metzger, & Borkovec, 1990) is a commonly-used, brief self-report measure of chronic, 
excessive and uncontrollable worry. Although the PSWQ is a valid and well-established 
measure of worry, its usefulness as a screening device for GAD is questionable because it 
does not assess for other GAD criteria such as the six associated somatic symptoms (i.e., 
feeling keyed up, easily fatigued, difficulty concentrating, irritability, muscle tension, 
problems with sleep) listed in DSM-IV. Unlike the PSWQ, the Generalized Anxiety 
Disorder Questionnaire - IV (GAD-Q-IV; Newman et al., 2002) is a self-report measure 
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that assesses all DSM-IV criteria for GAD. However, the GAD-Q-IV has a somewhat 
complicated scoring system. In addition, five questions on the GAD-Q-IV are answered 
with a dichotomous (yes/no) scale rather than a continuous scale. As mentioned 
previously, dichotomous scales are less than ideal because they often produce unreliable 
scores and because they generally do not assess symptom frequency or intensity. The 
remaining GAD-Q-IV items use a Likert scale with qualifiers that ask the respondent to 
rate their symptoms in terms of severity. However, symptom severity can be difficult to 
quantify because it is ultimately based on the subjective evaluation of a combination of 
many symptom attributes (e.g., frequency, duration, intensity). As noted by Dugas and 
Robichaud (2007), GAD worry is typically distinguished from non-clinical worry by 
quantitative, rather than qualitative differences in worry. Therefore, using qualifiers that 
measure frequency may be a more effective way to measure symptoms because 
frequency is arguably less complex, more concrete and easier for patients to quantify. 
Although many self-report GAD measures are theoretically sound, some are not 
used properly in clinical settings. In a review of screening measures for anxiety and 
depression, Balon (2005) notes that there are too many screening devices available for the 
same disorders, that clinicians use old and new screeners simultaneously, and that health 
professionals administer screening devices without proper training in their administration, 
scoring and interpretation. Furthermore, clinicians screening for GAD sometimes use 
measures that do not include all of the DSM-IV diagnostic criteria for the disorder. 
Therefore, there is a need for a standardized screening measure for GAD that can be 
quickly administered, and easily scored and interpreted. 
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The Worry and Anxiety Questionnaire (WAQ; Dugas et al., 2001) is an 11-item 
self-report screening instrument that was developed for the rapid assessment of GAD. 
Since its development, the WAQ has been used to screen for the presence of GAD, to 
assess the severity of GAD symptoms, and to measure changes in GAD symptoms over 
the course of psychotherapy. For example, the WAQ has been used to measured GAD 
symptom change over the course of individual therapy (Ladouceur et al., 2000), group 
therapy (Dugas et al., 2003), therapy for GAD-related insomnia (Belanger, Morin, 
Langlois, & Ladouceur, 2004), and drug tapering trials (Gosselin, Ladouceur, Morin, 
Dugas, & Baillargeon, 2006). Overall, the WAQ has been shown to be sensitive to 
treatment-related changes. 
Taken together, the items on the WAQ measure the DSM-IV diagnostic criteria 
for GAD. With the exception of the first question, all of the items on the WAQ measure 
symptoms on a 9-point Likert scale with three qualifying statements (for the lowest, 
middle and highest ratings on the scale). The qualifying statements vary depending on the 
question. The first question on the WAQ asks respondents to list up to six worry themes 
so that the clinician can obtain information about the nature (GAD or non-GAD) of the 
respondent's worry. For example, if all worry topics listed by the respondent relate to 
other psychological conditions (e.g., worry about social evaluation or about having a 
panic attack), then GAD can be ruled out. The second item asks respondents to rate the 
degree to which their worry is excessive (0 = Not at all excessive, 4 = Moderately 
excessive, 8 = Totally excessive) and the third item asks respondents to rate the frequency 
of their worry over the past 6 months (0 = Never, 4 = 1 day out of 2,8 = Everyday). 
Respondents are also asked to rate the difficulty they have controlling worry (0 = No 
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difficulty, 4 = Moderate difficulty, 8 = Extreme difficulty) and how much worry interferes 
with their life (0 = Not at all, 4 = Moderately, 8 = Very severely). The remaining six 
items measure how often the respondent experiences the six GAD somatic symptoms 
(i.e., including restlessness, fatigue, difficulty concentrating, irritability, muscle tension, 
and sleep disturbance). The qualifiers on this scale are: 0 = Not at all, 4 = Moderately, 
and 8 = Very severely. 
The original French version of the WAQ has demonstrated both sensitivity and 
specificity. For example, the questionnaire identified 89.5% of a sample with GAD as 
diagnosed by the Anxiety Disorders Interview Schedule for DSM-IY (ADIS-IV; Di 
Nardo, Brown, & Barlow, 1994) and misclassified only 5.3% of a non-clinical 
comparison group (Dugas et al., 2001). In addition, Dugas and colleagues (2001) found 
that scores on the French WAQ were related to pathological worry: 78.1% of participants 
who scored in the fourth quartile of the PSWQ met GAD criteria according to the WAQ 
whereas no participants in the first quartile of the PSWQ met the criteria. The French 
WAQ has also been shown to be sensitive to changes over treatment. For example, 
Ladouceur and colleagues (2000) found that scores on the Somatic subscale of the French 
WAQ decreased significantly after cognitive-behavioural therapy for GAD while scores 
remained unchanged in a wait-list control condition. Finally, the French WAQ has also 
showed evidence of good test-retest reliability: in one study, 75% of participants who met 
GAD criteria according to the WAQ at Time 1 met the same criteria when retested 2.5 
months later, whereas 82% of those who did not meet criteria at Time 1 also did not meet 
criteria at retest (Dugas et al., 2001). 
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Although the French version has been shown to have sound psychometric 
properties, the English translation of the WAQ has not yet been formally validated. In 
addition, previous experience with the WAQ suggests that the measure could be 
improved in a number of ways. Accordingly, the main goals of the current study were to 
revise the English version of the WAQ and conduct a preliminary investigation of the 
new measure's psychometric properties. Specifically, the original English version of the 
WAQ was revised based on a review of DSM-IV diagnostic criteria, a review of existing 
measures of GAD, consideration of the original measure's limitations, and consultation 
with experts in the area of GAD. Once the new measure was finalized, its psychometric 
properties were examined in an English-speaking undergraduate sample. 
Method 
Participants 
Participants were 163 undergraduate females and 50 undergraduate males ranging 
in age from 18 to 48 (M- 23.6, SD = 5.07). The undergraduates were recruited from the 
Department of Psychology Participant Pool or from non-psychology undergraduate 
classes at Concordia University. Table 1 presents demographic characteristics concerning 
participants' age, university status (full or part time), field of study, year of study, and 
ethnic origin. 
Table 1 
Demographic Characteristics of Participants 
Demographic Characteristic Female (n = 163) Male (n = 50) 
Age M SD M SD~ 
23.7 5.6 23.5 3.6 
% % 
University Status 
Full Time 84.0 92.0 
Part Time 14.7 6.0 
Field of Study 
Psychology 53.4 28.0 
Other 46.0 70.0 
Year of Study 
1st year 29.4 30.0 
2nd year 32.5 26.0 
3rd year 27.6 26.0 
Other 10.4 18.0 
Ethnicity 
Aboriginal 0.6 0 
African/Black 4.9 6.0 
Asian 9.8 6.0 
Bi-Racial 6.7 4.0 
European/White 66.9 68.0 
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Latino/a/Hispanic 1.2 0 
Middle Eastern 3.7 10.0 
Other 6.1 6.0 
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Measures 
Worry and Anxiety Questionnaire II (WAQ-II). The WAQ-II is the measure that 
was developed for the current study. It is a 13-item self-report questionnaire that 
measures DSM-IV diagnostic criteria for GAD. The WAQ-II is a revised version of the 
11-item Worry and Anxiety Questionnaire (WAQ; Dugas et al., 2001). For a detailed 
description of the changes that were made to the original WAQ, see Procedure section, 
(see Appendix A for a copy of the WAQ-II). 
Penn State Worry Questionnaire (PSWQ; Meyer et al.,1990). The PSWQ is a 16-
item self-report questionnaire that measures the trait-like tendency to worry on a 5-point 
Likert scale (where 1 = not at all typical and 5 = very typical). Examples include "My 
worries overwhelm me" and "As soon as I finish one task, I start to worry about 
everything else I have to do." The PSWQ has high internal consistency (a = .86 to .94; 
Brown, Antony, & Barlow, 1992), and excellent test-retest reliability after 8-10 weeks (r 
= .92; Meyer et al., 1990). The questionnaire shows evidence of convergent and 
discriminant validity (Brown et al.). For example, the PSWQ is correlated with other 
measures of worry such as the Student Worry Scale (r = .59) and the Worry Domains 
Questionnaire (r = .67), and it is more highly correlated with the Cognitive scale of the 
Cognitive Somatic Anxiety Questionnaire (r = .70) than with the Somatic scale (r = .55; 
Meyer et al., 1990) The internal consistency of the PSWQ in the current sample is a =.76 
(see Appendix B for a copy of the PSWQ). 
Padua Inventory — Washington State University Revision (PI-WSUR; Burns, 
Keortge, Formea, & Sternberger, 1996). The PI-WSUR is a 39-item self-report 
questionnaire designed to measure obsessions and compulsions on a 5-point Likert scale 
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(where 0 = not at all and 4 = very much). Example items include "When I read I have the 
impression that I have missed something important and I must go back and reread the 
passage at least two or three times" and "I think or worry at length about having hurt 
someone without knowing it." The PI-WSUR has a high internal consistency of a = .92 
and test-retest reliability of r = .16 after a 6- to 7-month interval. There is some evidence 
of discriminant validity given that the PI-WSUR only shares 12% of its variance with the 
PSWQ (Burns et al., 1996). Although the PI-WSUR total score is correlated with the 
PSWQ total score, each PI-WSUR item is more highly correlated with its corresponding 
subscale than with the PSWQ. The internal consistency of the PI-WSUR in the current 
sample is a =.92 (see Appendix C for a copy of the PI-WSUR). 
The Agoraphobic Cognitions Questionnaire (ACQ; Chambless, Caputo, Bright, & 
Gallagher, 1984). The ACQ is a 15-item self-report questionnaire that measures the 
frequency of specific cognitions when the respondent is anxious. The cognitions are 
measured on a 5-point Likert scale (where 1= thought never occurs when I am nervous 
and 5 = thought always occurs when I am nervous). Example items include "I am going 
to be paralyzed by fear" and "I am going to scream." The ACQ has high internal 
consistency (a =.80) and test-retest reliability (r = .86) in a clinical sample after a 31-day 
interval (Chambless et al.). The ACQ shows evidence of adequate convergent and 
discriminant validity as it can differentiate between individuals with panic and 
agoraphobia and those with other anxiety disorders (Chambless & Gracely, 1989) The 
internal consistency of the ACQ in the current sample is a =.87 (see Appendix D for a 
copy of the ACQ). 
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The Mobility Inventory (MI; Chambless, Caputo, Jasin, Gracely, & Williams, 
1985). The MI is a 26-item questionnaire that measures self-reported avoidance of 
situations such as grocery stores and high places when alone and when accompanied. 
Avoidance is measured on a 5-point Likert scale (where 1 = never avoid and 5 = always 
avoid). The MI has a high internal consistency of a = .94. The 8-day test-retest reliability 
of the Avoidance Alone subscale ranges from r = .89 to .90. There is also evidence that 
the MI can differentiate between agoraphobic respondents and non-clinical controls. 
Chambless et al. found that the Avoidance Alone subscale always significantly exceeded 
the Avoidance Accompanied scale in clinical respondents but not in the non-clinical 
sample. The MI is sensitive to change with treatment (Chambless et al.) The internal 
consistencies of the Avoidance Accompanied and Avoidance Alone scales in the current 
sample are a =.88 and a =.89, respectively (see Appendix E for a copy of the MI). 
Social Phobia Scale (SPS; Mattick & Clark, 1998). The SPS is a 20-item self-
report questionnaire that asks respondents to rate how they would react to specific social 
situations on a 5-point Likert scale ranging from 0 (not at all characteristic of me) to 4 
(extremely characteristic of me). Example items include "It would make me feel self 
conscious to eat in front of a stranger at a restaurant" and "I am worried people will think 
my behaviour is odd." The SPS has high internal consistency (a =.87 to .94 across 
clinical and community samples) and good to very good test-retest reliability over 4 to 12 
weeks (r = .66 to .93). There is some evidence of convergent and discriminant validity as 
clients with social phobia scored higher on the SPS than those with agoraphobia and non-
clinical individuals (Heimberg, Mueller, Holt, & Hope, 1992) The internal consistency of 
the SPS in the current sample is a =.92 (see Appendix F for a copy of the SPS). 
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Beck Depression Inventory 77 (BDI-II; Beck, Steer, & Brown, 1996). The BDI-II 
is a 21-item self-report questionnaire designed to measure depressive symptoms such as 
sadness and pessimism. Each item consists of 4 response options reflecting different 
degrees of depressive symptomology. For example, the four response options for sadness 
are "0 = I do not feel sad, 1 = I feel sad much of the time, 2 = lam sad most of the time, 
and 3=7am so sad or unhappy that I cannot stand it" The BDI-II has a high internal 
consistency of a = .93 and a 1-week test-retest reliability of r = .93. There is evidence of 
convergent and discriminant validity (Steer & Clark, 1997). The internal consistency of 
the BDI in the current sample is a =.91 (see Appendix G for a copy of the BDI). 
Illness Worry Scale (IWS; Robbins & Kirmayer, 1996). The IWS, which was 
derived from the Illness Behaviour Questionnaire (Pilowsky & Spence, 1983), is a 12-
item self-report questionnaire that measures the tendency to worry about being ill, to feel 
particularly sensitive to pain, and to be vulnerable to illness. Example items include "Do 
you think you worry about your health more than most people?" and "Do you get sick 
easily?" Each item is rated on a dichotomous (yes / no) scale. The IWS has moderate 
internal consistency (a = .70) and good 12-month test-retest reliability (r = .82) (Robbins 
& Kirmayer). There is some evidence of convergent validity as an earlier 9-item version 
of the IWS was correlated with the Whiteley Index of Hypochondriasis (Pilowsky, 1967). 
It can also differentiate between individuals with transient worries and those with more 
persistent illness worry (Robbins & Kirmayer). The internal consistency of the IWS in 
the current sample is a =.81 (See Appendix H for a copy of the IWS). 
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Procedure 
Questionnaire Development. Although the original version of the WAQ has 
proven useful in terms of the assessment of GAD diagnostic criteria (in both research and 
clinical settings), previous experience with the WAQ suggested that the measure could be 
improved in a number of ways (see Appendix I for a copy of the WAQ). The 
experimenter (A.D.) reviewed the Anxiety Disorders Interview Schedule for DSM-IV 
(ADIS-IV; Di Nardo et al., 1994) to create a measure that would adhere more closely to 
established methods of assessing DSM-IV diagnostic criteria for GAD. Several other 
GAD-related questionnaires were also reviewed to evaluate how the authors were able to 
reflect the DSM-IV criteria. The questionnaires were short self-report measures that 
assess GAD diagnostic criteria, worry, or trait anxiety (GAD-Q-IV: Newman et al., 2002; 
PSWQ: Meyer et al., 1990; GAD-7: Spitzer, Krocnke, Williams, & Lowe, 2006; State-
Trait Anxiety Inventory (STAT): Gaudry, Vagg, & Spielberger, 1975). Drafts of the 
questionnaire were presented to graduate students and clinical psychologists for 
feedback. 
Three major changes to the original version of the WAQ were made. First, a 
definition for worry was added to the WAQ-II. Although many GAD measures use the 
term "worry", none to our knowledge provide a definition of the construct. Given that 
intrusive thoughts such as worry, obsessions and depressive rumination share some 
characteristics, a comprehensive review of the literature on GAD, obsessive-compulsive 
disorder and depression was conducted to create a simple definition of worry that would 
have minimal overlap with obsessive thoughts and depressive rumination. Second, a 
question about level of distress was added because the original WAQ did not have a 
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question about GAD-related distress. Lastly, the Likert scale qualifiers were modified to 
make them more simple and concrete. The "sensation" qualifiers were altered so that they 
would describe frequency rather than severity and the frequency qualifiers were altered to 
make them easier to conceptualize (e.g., "1 out of 2 days" was modified so that it would 
read "50% of days"). 
A number of minor changes were also made to terminology to make the 
questionnaire more straightforward. For example, the term "sensations" was changed to 
"signs of anxiety" and examples were provided for terms such as "irritability" and 
"muscle tension." In addition, because each item had only three qualifiers on a 9-point 
Likert scale, it was difficult for respondents to qualify the other six points on the scale. 
As a result, two qualifiers were added to the Likert scales of the WAQ-II. 
Each question, with preliminary changes, was presented with the corresponding 
DSM-IV diagnostic criterion to a group of clinical psychology graduate students from the 
Anxiety Disorders Laboratory at Concordia University. The graduate students used their 
experience with the WAQ and other similar assessment tools to make pragmatic 
suggestions for revision. Next, the revised version of the questionnaire was sent to both 
graduate students and experts in the area of anxiety disorders. Specifically, the 
questionnaire was administered to five clinical psychology graduate students from 
outside the Anxiety Disorders Laboratory, for their revisions and comments. It was also 
sent to four external experts for their feedback. The external experts (Holly Hazlett-
Stevens, Douglas Mennin, Lizabeth Roemer, and Maureen Whittal) were researchers 
with expertise in the area of GAD assessment who were not affiliated with our research 
group. The questionnaire was then finalized for use in the current study. 
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Validation. Participants were recruited in two ways: through the Department of 
Psychology Participant Pool and from non-psychology undergraduate classes at 
Concordia University. For students recruited through the Participant Pool, the procedure 
was the following. After reading a description of the study on the Psychology 
Department's website, interested Participant Pool volunteers emailed the experimenter to 
make an appointment to participate in the study. Volunteers were tested in groups of 2 to 
10 participants in a testing room at Concordia University. At Time 1, participants were 
asked to sign a consent form outlining the procedure and the measures taken to ensure 
confidentiality of individual responses (see Appendix I). Participants completed a 
general information sheet and a test battery containing the eight questionnaires described 
previously. Approximately three weeks later, the same participants were contacted via 
email and asked to participate in the second part of the study. At Time 2, participants 
signed a second consent form and completed only one questionnaire, the WAQ-II. After 
completion, the experimenter explained the purpose of the research in greater detail and 
answered questions. All Participant Pool volunteers received course credit in a specified 
class for their participation in the study; those participating only at Time 1 received 0.5 
course credits, and those participating at both times received 1 course credit. 
For students recruited from non-psychology undergraduate classes, the following 
procedure was used. First, approximately 50 professors were sent formal letters 
requesting to have their class participate in the study. Four professors agreed to 
participate. The size of the participating classes ranged from 15 to approximately 100 
students. At Time 1, students who agreed to participate were asked to sign a consent form 
outlining the study procedure and the measures taken to ensure confidentiality of 
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individual responses; they were also informed that the completion of the first 
questionnaire package would take approximately 30 minutes. Participants then completed 
the general information sheet and the test battery containing the eight previously-
described questionnaires. Four weeks later, the professors were contacted and the Time 2 
testing was scheduled. At Time 2, participants signed a second consent form and 
completed the WAQ-II. After completion, the experimenter explained the purpose of the 
research in detail and answered any questions. Participants recruited in classes were not 
compensated for their participation. 
Results 
Preliminary Analyses 
All measures were screened for distribution skew and for the presence of 
multivariate and univariate outliers. To identify univariate outliers, z-score distributions 
were computed for each measure. Scores that fell 3.29 standard deviations above or 
below the mean were considered outliers and were removed from the data set (see 
Tabachnick & Fidell, 2007). Nine (9) univariate outliers were removed from the data set. 
To identify multivariate outliers, all measures were entered into a multiple regression and 
Mahalanobis distance was computed. Measures that did not meet the chi-square cut-off of 
p < .01 were considered multivariate outliers. Sixteen (16) multivariate outliers were 
removed from the data set. Finally, descriptive statistics were used to identify non-
normally distributed measures. The majority of the measures (i.e., the WAQ-II, BDI-II, 
PI-WSUR, SPS, IWS and the ACQ) were positively skewed. This result was expected 
because low scores are typically overrepresented in undergraduate samples when using 
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questionnaires designed to measure clinically significant psychopathology. Therefore, it 
was decided not to correct the positive skews on the aforementioned questionnaires. 
Sensitivity and Specificity 
To meet GAD criteria on the WAQ-II, respondents were required to endorse a 
response of at least 4 on the first three cognitive items (questions 2-4), on three of the six 
somatic items (questions 6a-e), and on the distress or the interference items (questions 7 
and 8). These diagnostic criteria were designed to reflect those of the DSM-IV. Question 
5 (i.e., difficulty controlling worry more days than not) was not included in the 
calculations because, although it is clinically useful, it does not reflect DSM-IV criteria. 
To examine the sensitivity and specificity of the WAQ-II in a non-clinical population, 
scores on the PSWQ were divided into quartiles and the proportion of participants 
meeting GAD criteria on the WAQ-II was assessed in each quartile. Overall, the WAQ-II 
showed evidence of specificity. For example, no participants in the first quartile of the 
PSWQ (M= 32.10, SD = 5.08) met criteria for GAD as measured by the WAQ-II. The 
WAQ-II diagnostic criteria also showed evidence of sensitivity; 37% of participants in 
the fourth quartile of the PSWQ (M= 63.35, SD = 5.71) met WAQ-II criteria for GAD. 
The results for the four PSWQ quartiles are presented in Figure 1. The WAQ-II had a 
high internal consistency (a = .93). 
Convergent and Discriminant Validity 
A continuous scoring system was also developed to reflect the severity of the 
different GAD symptom clusters. A total score on the WAQ-II was computed by dividing 
the total score of the somatic items (questions 6a-e) and the distress/interference items 
(questions 7 and 8) by 2 and adding those to the total score on the first three cognitive 
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items (questions 2-4). For example, if a respondent received a total score of 45 on the 
somatic items (e.g., restlessness, fatigue, difficulty concentrating) and a total score of 15 
on questions 7 and 8, the two scores would be added together (45 + 15 = 60) and divided 
by two (60/2 = 30). That score would be added to the total cognitive score. For example, 
if the total cognitive score was 24, the overall WAQ-II score for the respondent would be 
54 (30 + 24 = 54). This scoring system was chosen so that the cognitive and somatic 
symptoms would be given equal weight in the calculation of the overall score. 
Specifically, the maximum total score for the cognitive items ( 8 x 3 = 24) is equal to the 
maximum total score for the somatic items ( 8 x 6 / 2 = 48/2 = 24). 
The convergent and discriminant validity of the WAQ-II continuous scores was 
initially evaluated using Pearson correlations. As anticipated, WAQ-II total scores were 
significantly correlated with scores on the measures of worry, depression, anxiety, and 
hypochondriasis (PSWQ, BDI-II, PI-WSUR, SPS, ACQ, MI, and IWS) (see Table 2). A 
series of comparisons of non-independent correlation coefficients using Fisher r-to-z 
transformations were conducted to measure the specificity of WAQ-II continuous scores 
with regards to scores on the PSWQ, which is the measure that is theoretically most 
closely linked to the WAQ-II. As expected, WAQ-II total scores were significantly more 











































































































































































































































































































































































































































































































































































































































To further examine the convergent and discriminant validity of the WAQ-II, a 
hierarchical regression was carried out using WAQ-II total scores as the dependent 
variable. In the first step, demographics (age and sex) were entered and made a 
significant contribution to WAQ-II total scores, F(2,200) = 5.28, p < .01. However, 
neither variable on its own significantly predicted WAQ-II scores. In the second step, all 
measures but the PSWQ (i.e., BDI-II, PI-WSUR, SPS, ACQ, MI-ACC, MI-ALONE, 
IWS) were entered and explained an additional 49.5% variance in WAQ-II scores, F(7, 
193) = 28.88,;? < .001. BDI-II, PI-WSUR and SPS scores were significant predictors of 
WAQ-II scores in this step. Finally, the PSWQ was added in the third step and accounted 
for an additional 15% of the variance in WAQ-II scores F(l, 192) = 91.60,;? < .001. 
Although the BDI-II and SPS scores remained significant predictors of WAQ-II total 
scores in this step, the PSWQ made the highest contribution to WAQ-II total scores in the 
final model as evidenced by the beta weights (see Table 3). 
Test-Retest Reliability 
Pearson correlations were also used to assess the test-retest reliability of the 
WAQ-II. Time 1 WAQ-II total scores were significantly correlated with Time 2 WAQ-II 
total scores, r(\\l) = .79, p < .01. Furthermore, comparisons of non-independent 
correlation coefficients using Fisher r-to-z transformations found that Time 1 WAQ-II 
total scores were significantly more highly correlated with WAQ-II Time 2 total scores 
than with the total scores of the other measures. To further examine the test-retest 
reliability of the WAQ-II, agreement of GAD diagnoses was assessed across the two time 
points. Forty-seven percent (47%) of people who met criteria on the WAQ-II at Time 1 
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continued to meet criteria at Time 2. Furthermore, 95% of people who did not meet 
criteria on the WAQ-II at Time 1 continued to not meet criteria at Time 2. 
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Table 3 
Summary of Hierarchical Multiple Regression Predicting Scores on the WAQ-II (N 
202) 




































































PI-WSUR .056 0.030 0.096 
SPS .149 0.050 0.172* 
ACQ -.036 0.066 -0.030 
MI-ACC .077 0.067 0.070 
MI-AL -.051 0.046 -0.075 
IWS .022 0.213 0.005 
Note: WAQ-II = Worry and Anxiety Questionnaire II (WAQ-II); BDI-II = Beck 
Depression Inventory-II; PI-WSUR = Padua Inventory - Washington State University 
Revision; SPS = Social Phobia Scale; ACQ = Agoraphobic Cognitions Questionnaire; 
MI-ACC = Mobility Inventory-Accompanied; MI-AL = Mobility Inventory Alone; IWS 
= Illness Worry Scale: PSWQ = Perm State Worry Questionnaire. 





The purpose of this research was to revise and validate an existing screening 
questionnaire for Generalized Anxiety Disorder (GAD). Specifically, we revised the 
Worry and Anxiety Questionnaire (WAQ) in order to make it more objective, easier to 
understand and more consistent with the DSM-IV criteria for GAD. It was anticipated 
that the WAQ-II would show evidence of sensitivity, specificity, convergent and 
discriminant validity, and test-retest reliability. 
Sensitivity and Specificity 
There was evidence that the WAQ-II has potential as a sensitive and specific 
measure of GAD. As anticipated, none of the participants scoring in the first quartile of 
the PSWQ met criteria for GAD as assessed by the WAQ-II. On the other hand, 37% of 
participants scoring in the fourth quartile of the PSWQ met criteria for GAD according to 
the WAQ-II. Taken together, these results provide evidence that high worriers are more 
likely to be diagnosed with GAD by the WAQ-II than low worriers. Given that excessive 
worry is the main feature of GAD, these results provide preliminary evidence that the 
WAQ-II may be a useful screening tool for GAD. The relationship between the WAQ-II 
and worry was also evident when continuous WAQ-II scores were considered. WAQ-II 
total scores and total PSWQ scores were highly correlated (r = .73). In fact, the 
correlation obtained in the present study was as high as the correlation between the GAD-
Q-IV and the PSWQ (r = .66) obtained in a previous study (Newman et al., 2002). It 
should be noted however, that although pathological worry is the hallmark of GAD, it is 
not the only symptom of GAD. Therefore, it is not surprising that many high scorers on 
the PSWQ were not diagnosed with GAD (63%). 
Interestingly, 2% of individuals who scored in the second quartile and 19% of 
individuals who scored in the third quartile of the PSWQ met criteria for GAD according 
to the WAQ-II. Although these individuals were not high worriers according to the 
PSWQ (they could be considered moderate worriers), they met criteria for GAD on the 
WAQ-II. This result is consistent with those of Behar, Alcaine, Zuellig and Borkovec 
(2003), who found that the PSWQ has relatively low sensitivity and positive predictive 
power for GAD in a student sample. Obviously, given the complexity of GAD diagnostic 
criteria, the assessment of worry level is insufficient to accurately identify individuals 
with the disorder. The current findings suggest that some individuals who meet GAD 
criteria by the questionnaire may not have extreme levels of worry yet still consider that 
their worry and anxiety cause significant interference and distress. 
Distinguishing GAD worry from normal worry has been a challenge since the 
DSM-III-R (American Psychiatric Association (APA), 1987) first included the notion of 
pathological worry in the definition of GAD. In their research on the diagnostic reliability 
of the anxiety disorders, Chorpita, Brown and Barlow (1998) found that specific 
behavioural markers increase the diagnostic reliability of anxiety disorders. They noted 
that GAD is particularly difficult to diagnose because worry is fundamentally an internal 
cognitive event that typically has few overt manifestations or consequences. Thus 
although excessive and uncontrollable worry is theoretically specific to GAD, it can be 
very difficult to assess given its covert nature. By measuring the frequency of worry (as 
opposed to exclusively focussing on the excessive and uncontrollable nature of worry), 
the WAQ-II may facilitate the assessment of GAD. Obviously, by also assessing the 
somatic symptoms of GAD, the WAQ-II provides a more comprehensive assessment of 
GAD than measures of worry such as the PSWQ. 
Convergent and Discriminant Validity 
It was not surprising that WAQ-II scores were significantly correlated with scores 
on measures of OCD, panic, social anxiety, agoraphobia, and health anxiety given the 
well documented symptom overlap and comorbidity between these disorders and GAD 
(e.g., Brown, Campbell, Lehman, Grisham, & Mancill, 2001). Despite this overlap, 
however, WAQ-II scores were significantly more highly correlated with PSWQ scores 
than with scores on the other measures of anxiety and depression. Similarly, Newman et 
al. (2002) found that GAD-Q-IV scores were more highly correlated with PSWQ scores 
than with scores on measures of panic and social phobia. However, Newman et al. did not 
include measures of OCD, agoraphobia, health anxiety and depression in their study; 
therefore, it is not know if the GAD-Q-IV is more closely related to measures of worry 
than to measures of the aforementioned disorders. In the current study, the WAQ-II also 
showed evidence of discriminant validity in the hierarchical regression; the PSWQ made 
the strongest contribution to the prediction of WAQ-II total scores. These results suggest 
that the WAQ-II may be able to discriminate between worry and symptoms of other 
anxiety disorders and depression. 
In addition to PSWQ scores, BDI-II and SPS scores also made significant 
contributions to the prediction of WAQ-II total scores in the final regression model. This 
result was not surprising given that GAD, depression and social anxiety have much in 
common in terms of their phenomenology and tend to co-occur in the same individuals 
(Dugas & Robichaud, 2007). For example, Kessler, Walters, and Wittchen (2004) have 
reported that depression and GAD may share a common genetic predisposition, and that 
GAD may be more closely linked to depression than to other anxiety disorders - with the 
possible exception of social anxiety disorder (Kessler et al., 2004). Not surprisingly, 
depression is the most commonly diagnosed comorbid condition in individuals with 
GAD. 
The close association between GAD and social anxiety found in this study has 
also been reported in previous studies. For example, Ladouceur, Freeston, Fournier, 
Dugas and Doucet (2002) investigated worry content by conducting a factor analysis on 
the Worry Domains Questionnaire (WDQ; Tallis, Eysenck, & Mathews, 1992) in high 
school, university and older adult samples. The first factor they extracted in high school 
and university samples reflected social-evaluative concerns. The social-evaluative factor 
accounted for the greatest amount of variance in the tendency to worry; i.e., it was the 
best predictor of the global tendency to worry. Similarly, when Lovibond and Rapee 
(1993) asked participants to rate their concern with certain negative outcomes on the 
Negative Outcomes Questionnaire, they extracted two factors labelled "physical 
concerns" and "social concerns." Only the social concerns factor was correlated with 
worry as measured by the PSWQ. Thus, given that GAD worry is ultimately 
characterized by social-evaluative issues and that GAD and depression may have a 
common genetic predisposition (as well as high comorbidity rates), the unique 
contributions of the SPS and BDI-II to the prediction of WAQ-II scores were not entirely 
unexpected. 
Test-Retest Reliability 
The findings of the current study also showed that WAQ-II categorical and 
continuous scores were relatively stable. Approximately half of the participants who met 
DSM-TV GAD criteria on the WAQ-II at Time 1 continued to meet criteria at Time 2 and 
95% of participants who did not met criteria on the WAQ-II at Time 1 continued to not 
meet criteria at Time 2. In the original validation study of the WAQ, Dugas et al. (2001) 
found that 75% of the sample who met criteria on the WAQ at Time 1 also met criteria at 
Time 2 and 82% of the sample who did not meet criteria on the WAQ at Time 1 also did 
not meet criteria at Time 2. Thus, the WAQ and WAQ-II appear to have similar test-
retest reliability (although both have not been tested in the same study). In the GAD-Q-
IV validation study, Newman et al. (2002) found that 92% of their sample stayed in the 
same category from Time 1 to Time 2. Thus, the GAD-Q-IV may be more temporally 
stable than either the WAQ or the WAQ-II. However, it should be noted that in the 
Newman et al. study, participants could be classified as having "GAD" without meeting 
the DSM-IV criteria for the disorder (their GAD diagnostic cutoff on the GAD-Q-IV was 
numerically determined and not directly based on DSM-IV criteria). 
In summary, the results of this research suggest: (1) that high worriers are more 
likely to be diagnosed with GAD on the WAQ-II than low worriers; (2) that although 
WAQ-II scores are associated with scores on measures of different anxiety disorders and 
depression, they are most highly related to scores on a measure of worry; (3) that 
measures of worry, social anxiety and depression all made unique contributions to the 
prediction of WAQ-II scores; and (4) that the WAQ-II shows evidence of temporal 
stability over three weeks, regardless of if it is scored continuously or categorically. 
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Clinical Implications 
An important strength of the WAQ-II is that it can be scored either continuously 
or categorically. Continuous and categorical scoring systems can be used for different 
clinical purposes because they each have specific strengths and weaknesses. One 
advantage of a continuous scoring system is that it provides an assessment of symptom 
severity (and is not overly-dependent on DSM-IV diagnostic criteria). The WAQ-II 
continuous scoring system was designed to give equal weight to the cognitive and 
somatic symptoms in the overall score. This is an important strength of the WAQ-II 
because the clinician can directly compare the severity of the cognitive and somatic 
symptoms and use that information to help create a treatment plan. Another advantage of 
the continuous scoring system is that it allows both the patient and clinician to monitor 
change over time. For example, the WAQ-II can be administered weekly (e.g., the patient 
can complete the WAQ-II in the waiting room before his/her weekly session) and the 
course of change can be charted over therapy. Generally, a continuous scoring system is 
helpful when the clinician would like to assess symptom severity or monitor symptom 
change over the course of therapy. However, there are situations where a categorical 
classification may be more helpful. 
A categorical classification system can be used to help clinicians make treatment 
decisions where resources are limited. To receive services or insurance coverage, patients 
are often required to receive a "diagnosis." The WAQ-II can be used as a preliminary 
way to categorize individuals as either "clinical" or "non-clinical." After the preliminary 
classification, the WAQ-II should of course be followed-up with a formal diagnostic 
assessment. Given that self-report screening measures such as the WAQ-II tend to 
produce a fair amount of false positives (diagnosing GAD when it is in fact not present) 
but very few false negatives (not recognizing GAD when it is in fact present), these 
measures are ideal for screening because the vast majority of individuals will not be 
screened out before a formal diagnostic assessment (i.e., few false negatives). In other 
words, there is little chance that someone suffering from a clinically-significant disorder 
(as defined by the DSM-IV) will not be properly assessed. However, it should be kept in 
mind that if the categorical system is used alone, information about the patient is lost 
because the system does not provide information about symptom severity. In addition, 
individuals experiencing considerable distress or interference in only one or two areas 
may not be identified as needing treatment because they would be classified as "non-
disordered" using the categorical system. Therefore, the obvious conclusion is that it is 
often advantageous to use both systems; one to assess symptom severity and monitor 
symptom change, and the other to map onto DSM-IV criteria, to communicate with third 
parties and to make decisions about subsequent formal diagnostic assessments. 
Study Limitations 
One of the limitations of this research was the use of the PSWQ to assess the 
sensitivity and specificity of the WAQ-II. Although the PSWQ is a well-established 
measure of worry, its value as a GAD screener is limited because it does not assess the 
somatic symptoms of anxiety or directly measure interference and functional impairment. 
The close relationship between the WAQ-II and the PSWQ found in this study provides 
evidence that the cognitive items of the WAQ-II (those that relate to worry) appear to be 
valid; however, the validity of the somatic symptom items (and to a lesser extent, the 
interference and distress items) cannot be determined from the current findings. Ideally, it 
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would have been preferable to compare the WAQ-II to a diagnostic interview such as the 
ADIS-IV (Di Nardo et al., 1994) to arrive at conclusions about the suitability of the 
WAQ-II as a GAD screener. 
The conclusions that can be drawn from this research are also limited because the 
WAQ-II was not tested in a clinical population. If the WAQ-II is an effective screening 
tool for GAD, it should be able to reliably differentiate between patients with GAD, 
patients with other disorders and non-clinical controls. The sensitivity, specificity, 
convergent and discriminant validity, and test-retest reliability of the WAQ-II must also 
be evaluated in a clinical population before it can reliably be used as a screening tool. 
Relatedly, the generalizability of the current results is limited because the sample was not 
very diverse in terms of socio-demographic characteristics and psychopathology. The 
research was limited to undergraduate students whose symptoms of anxiety may have 
been very different from people formally diagnosed with GAD and from non-clinical 
community controls. 
A third limitation of this study was that the impact of the revisions to the original 
version of the WAQ was not directly assessed. This research would have been more 
informative if the original version of the WAQ had been compared to the WAQ-II in the 
same sample. This would have allowed us to examine whether the WAQ modifications 
made a difference in terms of the sensitivity, specificity, validity and temporal stability of 
the GAD screening measure. Although the inclusion of the original version of the WAQ 
would not have allowed us to determine the impact of individual changes made to the 
WAQ-II, it would have nonetheless allowed us to assess the impact of the combination of 
all changes made to the questionnaire. Since one of the goals of the revisions was to 
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make the questionnaire easier to understand, future research should ask participants to 
rate the readability or "understandability" of the questionnaire items. Ideally, this study 
would have compared both the WAQ and WAQ-II to the ADIS-IV (Di Nardo et al., 
1994) to determine if the modifications made to the WAQ-II rendered the questionnaire 
more reliable. 
Future Directions 
Although the results of this research are encouraging, more research is necessary 
to determine whether the WAQ-II is an effective screening device for GAD. First, as 
mentioned above, the WAQ-II should be validated in a clinical population by comparing 
it to a well-established GAD assessment tool such as the ADIS-IV (Di Nardo et al., 
1994). By using a clinical population, investigators could determine whether WAQ-II 
scores relate to important clinical variables such as functional impairment and quality of 
life. In addition, Receiver Operating Characteristics analyses (ROC) could be conducted 
with the ADIS-IV to determine a WAQ-II cutoff score that provides an optimal balance 
between sensitivity and specificity. Second, the WAQ-II should be compared to other 
short, self-report GAD screening questionnaires to determine which questionnaires have 
the strongest relationship with the ADIS-IV and the highest test-retest reliability. Finally, 
treatment studies could be used to evaluate the extent to which the WAQ-II is sensitive to 
change over treatment. 
Overall, the results of this research suggest that the WAQ-II shows promise as a 
screening measure for GAD. If the WAQ-II is found to be a reliable and valid measure in 
clinical populations, it is anticipated that it will be especially useful for identifying 
individuals whose symptoms of anxiety may have otherwise been overlooked in primary 
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care. Although GAD occurs frequently and has a tremendous personal and social impact, 
it is under diagnosed. A screening tool such as the WAQ-II may prove to be clinically 
useful if it facilitates the identification of GAD and ultimately helps GAD sufferers 
receive effective treatment. 
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Figure 1. Percent of participants in each of the four quartiles of the PSWQ meeting 

























Many people talk about worry. The following is a definition of worry: 
"Worry is a chain of upsetting thoughts about something bad that could happen to you or to others." 
Please keep this definition in mind when you answer the questions on this form. 
1. What do you worry about most often? 
a): ! _ _ _ e ) _ _
 : . 
b)




2. Do you think your worries are excessive? In other words, are they blown out of proportion? 
Not at all Slightly Moderately Very Much Extremely 
0 1 2 3 4 5 6 7 8 
3. Over the past 6 months, how often have you had excessive worries? 
Never Some days 50% of days Most days Everyday 
0 1 2 3 4 5 6 7 8. 
4. Do you think you have problems controlling your worry? 
(For example, once you start to worry, you feel like you cannot stop.) 
Not at all Slightly Moderately Very Much Extremely 
0.. 1 2 3 4 5 6 , 7 8 
5. How often do you have problems controlling your worry? 
Never Some days 50% of days Most days Everyday 
0 1 2 3 4 5... 6. 7 8 
WAQ-II Page 1 of 2 
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6. Over the last 6 months, how often did you experience the following signs of anxiety? 
a) Restlessness or being "keyed up" or "on edge" 
Never Some days 50% of days Most days Everyday 
0 1 2 3 4 .'...5 6 7 ...8....... 
b) Tiring easily 
Never Some days 50% of days Most days Everyday 
0 1 2 3 4 5 6 7 ..8 
c) Trouble concentrating 
Never Some days 50% of days Most days Everyday 
0 1 2 3 4 5 6 ...7 8 
d) Irritability (being easily annoyed or angered) 
Never Some days 50% of days Most days Everyday 
0 1 2 3 .4 5 6 7 8 
e) Muscle tension (often pain or tightness in the face, neck, shoulders or back) 
Never Some days 50% of days Most days Everyday 
0 1 2 3 ...A 5 6 7 8........ 
f) Problems sleeping (problems falling asleep, problems staying asleep, having restless 
or unsatisfying sleep) 
Never Some days 50% of days Most days Everyday 
0 1 2 3 4 5 6 7 8........ 
7. To what extent do worries and/or the signs of anxiety listed in question 6 interfere with your life? 
(For example your job, daily routine, social life or family life.) 
Not at all Slightly Moderately Very Much Extremely 
0 1 2 3 1 4 5 6 7 8 
8. To what extent do your worries and/or the signs of anxiety listed in question 6 upset you 
or bother you? 
Not at all Slightly Moderately Very Much Extremely 
0.. 1 2 3 4 5 6 7 8 
Doucet A., & Dugas. M. J (2006). Anxiety Disorders Laboratory, Concordia University, Montreal, Quebec. 
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Appendix B 
Penn State Worry Questionnaire (PSWQ) 
PSWQ 48 
PSWQ 
Please circle a number (1 to 5) that best describes how typical or characteristic each item is of you. 
1. If I don't have enough time to do 
everything, I don't worry about i t . 
Not at all 
typical 
2, My worries overwhelm me. 
3. I don't tend to worry about things. 
4. Many situations make me worry. 
5. I know I shouldn't worry about 
things but I just can't help it 
6. When I'm under pressure, I worry a lot. 
7.1 am always worrying about something. 
8.1 find it easy to dismiss worrisome thoughts.. 
9. As soon as I finish one task, I start to 
worry about everything else I have to do. 
10.1 never worry about anything. 
11. When there is nothing more that 
I can do about a concern, I don't 
worry about it anymore 
12. I've been a worrier all my life. 
13. I notice that I have been 
worrying about things. 
14. Once I start worrying, I can't stop 
15. I worry all the time 














Meyer, T. J., Miller, M. L„ Metzger, R. L., & Borkovec, T. D. (1990). 
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Appendix C 
Padua Inventory - Washington State University Revision (PI-WSUR) 
PI-WSUR 
PI-WSUR 
The following statements refer to thoughts and behaviours which may occur to everyone 
in everyday life. For each statement, choose the reply which best seems to fit you and the 
degree of disturbance which such thoughts or behaviours may create. Rate your replies as follows: 
Not at all A little Quite a lot A lot Very much 
1. I feel my hands are dirty 
when I touch money 0... 1 2 3 4 
2. I think even the slightest contact with 
bodily secretions (perspiration, 
saliva, urine, etc.) may contaminate 
my clothes or somehow harm me 0 1 2 3 4 
3.1 Find it difficult to touch an object 
when I know it has been touched 
by strangers or by certain people 0 1 2. 3 4 
4. I find it difficult to touch 
garbage or dirty things. 0 1 2 3 4 
5.1 avoid using public toilets because I 
am afraid of disease or contaminatior 0 1 .....2 3 ..4 
6.1 avoid using public telephones 
because I am afraid of 
contagion or disease 0 1 2 3 4 
7. I wash my hands more often 
and longer than necessary 0 1 2 3. 4 
8. I sometimes have to wash or clean 
myself simply because I think I 
may be dirty or "contaminated." 0 1 .....2 3 4 
9. If I touch something I think is 
contaminated I immediately 
have to wash or clean myself. 0... 1 2 3 4 
10. If an animal touches me, I 
feel dirty and immediately 
have to wash myself or 
change clothes 0 1 2 3 4 
PI-WSUR Page 1 of4 
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Not at all A little Quite a lot A lot Very much 
11.1 feel obligated to follow a particular 
order in dressing, undressing, 
and washing myself. 0 1 2 3 4 
12. Before going to sleep, I have to 
• do certain things in a certain order 0 1 2 3 4.. . . . . . 
13. Before going to bed, I have to hang up 
or fold my clothes in a special way 0 1 2 3 4 
14.1 have to do things several 
times before I think they 
are properly done 0 1 2 . . . , 3 . . . 4 
15.1 tend to keep checking things 
more often than necessary. 0 1 2 3... 4 
16.1 check and recheck gas and 
water taps and light switches 
after turning them off. , 0 1 2 3 4 
17. I return home to check doors, 
windows, drawers, etc., 
in detail to make sure 
they are properly shut 0 1 2. 3 4 
18.1 keep checking forms, 
documents, checks, etc., in 
detail to make sure I have 
filled them in correctly. 0 1 2 3 4 
19.1 keep going back to see 
that matches, cigarettes, 
etc., are properly 
extinguished 0 1 2 3 4 
20. When I handle money, I count 
and recount it several times 0 1 2 3 4 
21.1 check letters carefully many 
times before posting them. 0 1 2 3 4 
22. Sometimes, I am not sure I 
have done things, which in 
fact I know I have done 0 1 2 3 4 
PI-WSUR Page 2 of 4 
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Not at all A little Quite a lot A lot Very much 
23. When I read, I have the 
impression I have missed 
something important and 
must go back and reread the 
passage at least two or 
three times 0 1 2 3 4 
24.1 imagine catastrophic 
consequences as a result of 
absent mindedness or minor 
errors, which I make 0 1 2 3 4 
25.1 think or worry at length 
about having hurt someone 
without knowing it 0 1 2 3 4 
26. When I hear about disaster, I think 
it is somehow my fault 0 1 2 3 4 
27. I sometimes worry at length 
for no reason that I have hurt 
myself or have some disease 0 1 2 3 4 
28.1 get upset and worried at 
the sight of knives, daggers, 
and other pointed objects 0.... 1 2 3 4 
29. When I hear about suicide 
or crime, I am upset for a 
long time and find it difficult 
to stop thinking about it 0 1 2 3 4 
30.1 invent useless worries 
about germs and disease .0 1 2 3 4 
31. When I look down from a bridge 
or a very high window, I feel the 
impulse to throw myself into space 0.... 1 2 3 4 
32. When I see a train approaching, 
I sometimes think I could throw 
myself under its wheels. 0 1 2 3 4 
PI-WSUR Page 3 of 4 
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Not at all A little Quite a lot A lot Very much 
33. At certain moments, I am tempted 
to tear off my clothes in public 0 1 2 3 4 
34. While I am driving, I sometimes 
feel an impulse to drive the car 
into someone or something 0 1 2 3 4 
35. Seeing weapons excites me and makes 
me think violent thoughts 0 1 2 3 4 
36.1 sometimes feel the need to break or 
damage things for no reason 0 1 2 3 4 
37.1 sometimes have an impulse to steal 
other people's belongings, even if they 
areofnousetome 0 1 2 3 4.. . . . . . 
38.1 am sometimes almost irresistibly 
tempted to steal something from the 
supermarket 0 1 2 3 4 
39.1 sometimes have an impulse to hurt 
defenseless children or animals. .... ..0 1 2 3 4 
Page 4 of4 
Bums, G. L'. (1995). Padua Inventory - Washington State University Revision. Pullman, WA: Author. 
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Appendix D 
Agoraphobic Cognitions Questionnaire (ACQ) 
ACQ 55 
ACQ 
Below are some thoughts or ideas that may pass through your mind when you are nervous or frightened. 
Please indicate how often each thought occurs when you are nervous. Rate from 1-5 using the scale below. 
Please rate all items. 
Thought 
Thought Thought occurs Thought Thought 
never rarely during half usually always 
occurs occurs of the time occurs occurs 
when I am when I am when I when I am when I am 
nervous nervous am nervous nervous nervous 
1. I am going to throw up 1 , 2 3. 
2. I am going to pass out 1 2. 
3. I must have a brain tumor 1 2 3 4. 
4. I will have a heart attack 1.. 2 3 4 . . . 5 . 
5. I will choke to death 1 2. 
6. Iamgoingtoactfool ish 1 .....2 3. 
7. I am going blind 1 2 3 4 . 
8. I will not be able to control myself. 1 2 3 4 . . . . 5 . 
9. I will hurt someone 1 2 3 4. 
10.1 am going to have a stroke 1 2 3 4. 




when I am 
nervous 
11.1 am going crazy 1...... 
12. I am going to scream 1 
13.1 am going to babble or talk funny 1 
14. I am going to be paralyzed by fear. ........1 
15. Other ideas not listed (please 
describe and rate them) 1 
Thought 
Thought occurs Thought Thought 
rarely during half usually always 
occurs of the times occurs occurs 
when I am when I when I am when I am 
nervous am nervous nervous nervous 
2, 3 4 5 
2. . . . . 3 4 5 
2 3 ...4 5 
2 3 4 . . . . .5 
2. . . . 3 4. . . 5 
Page 2 of2 
© 1984 Dianne L. Chambless. Reprinted with permission. 
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Social Phobia Scale (SPS) 
SPS 63 
SPS 
For each question, please circle a number to indicate the degree to which you feel the statement is 
characteristic or true of you. The rating scale is as follows: 
Not at all Slightly Moderately Very Extremely 
1. I become anxious if I have to 
write in front of other people 0 1 2 .3 4 
2. I become self-concious 
when using public toilets 0
 r.l ..2 3 4 
3. I can suddenly become 
aware of my own voice 
and of others listening to me. 0 1 2 3 4 
4. I get nervous that people are staring 
at me as I walk down the street 0 1 2 . .3 . . . 4 
5. I fear I may blush 
when I am with others. 0 1 2 3. . . . . 4 
6. I feel self concious if I have 
to enter a room where 
others are already seated .0 1 2 3 4 
7. I worry about shaking 
or trembling when I'm 
watched by other people 0 1 2 ..3 4 
8. I would get tense if I 
had to sit facing other 
people on a bus or a train. 0 1 2 3 4 
9. I get panicky that others might 
see me to be faint, sick, or ill 0 1 2 3 4 
10. I would find it difficult to drink 
something if in a group of people 0 1 2 3 4 
SPS 
64 
Not at all Slightly Moderately Very Extremely 
11. It would make me feel 
self-conscious to eat in front 
of a stranger at a restaurant. 
12.1 am worried people will 
think my behaviour odd. ... .0. 
13.1 would get tense if I had to carry 
a tray across a crowded cafeteria. 0. 
14. I worry I'll lose control of 
myself in front of other people 0. 
15.1 worry I might do something 
to attract the attention 
of others 
16. When in an elevator I am 
tense if people look at me. 
17.1 can feel conspicuous 
standing in a queue 
18.1 get tense when I speak 
in front of other people. 
19. I worry my head will shake 
or nod in front of others. . .0. 
20. I feel awkward and tense if 
I know people are watching me 0. 
.4. 
.4. 
Page 2 of2 
Mattick, R.P., & Clark, J.C. (1998). Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. 
Behavior Research and Therapy, 36, 455-470. 
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Appendix G 




This questionnaire consists of 21 groups of statements. Please read each group of statements carefully, 
and then pick out the one statement in each group that best describes the way you have been feeling 
during the past two weeks, including today. Circle the number beside the statement you have picked. 
If several statements in the group seem to apply equally well, circle the highest number for that group. 
Be sure that you do not choose more than one statement for each group, including Item 16 (Changes 
in Sleeping Pattern) or Item 18 (Changes in Appetite). 
1) Sadness 
0 I do not feel sad. 
1 I feel sad much of the time. 
2 I am sad all the time. 
3 I am so sad or unhappy that I can't stand it. 
2) Pessimism 
0 I am not discouraged about my future. 
1 I feel more discouraged about my future than I used to be. 
2 I do not expect things to work out for me. 
3 I feel my future is hopeless and will only get worse. 
3) Past Failure 
0 I do not feel like a failure. 
1 I have failed more than I should have. 
2 As I look back, I see a lot of failures. 
3 I feel I am a total failure as a person. 
4) Loss of Pleasure 
0 I get as much pleasure as I ever did from the things I enjoy. 
1 I don't enjoy things as much as I used to. 
2 I get very little pleasure from the things I used to enjoy. 
3 I can't get any pleasure from the things I used to enjoy. 
5) Guilty Feelings 
0 I don't feel particularly guilty. 
1 I feel guilty over many things I have done or should have done. 
2 I feel quite guilty most of the time. 
3 I feel guilty all of the time. 
BDi-n Page 1 of4 
6) Punishment Feelings 
0 I don't feel I am being punished. 
1 I feel I may be punished. 
2 I expect to be punished. 
3 I feel I am being punished. 
7) Self-Dislike 
0 I feel the same about myself as ever. 
1 I have lost confidence in myself. 
2 I am disappointed in myself. 
3 I dislike myself. 
8) Self-Criticalness 
0 I don't criticize or blame myself more than usual. 
1 I am more critical of myself than I used to be. 
2 I criticize myself for all my faults. 
3 I blame myself for everything bad that happens. 
9) Suicidal Thoughts or Wishes 
0 I don't have any thoughts of killing myself 
1 I have thoughts of killing myself, but I would not carry them out. 
2 I would like to kill myself. 
3 I would kill myself if I had the chance. 
10) Crying 
0 I don't cry any more than I used to. 
1 I cry more now than I used to. 
2 I cry over every little thing. 
3 I feel like crying but I can't. 
11) Agitation 
0 I am no more restless or wound up than usual. 
1 I feel more restless or wound up than usual. 
2 I am so restless or agitated that it's hard to stay still. 
3 I am so restless or agitated that I have to keep moving or doing something. 
12) Loss of Interest 
0 I have not lost interest in people or activities. 
1 I am less interested in other people or things than before. 
2 I have lost most of my interest in other people or things. 
3 It's hard to get interested in anything. 
BDi-n 
13) ladecisiveness 
0 I make decisions about as well as ever. 
1 I find it more difficult to make decisions than usual. 
2 I have much greater difficulty in making decisions than I used to. 
3 I have trouble making any decision. 
14) Worthlessness 
0 I do not feel I am worthless. 
1 I don't consider myself as worthwhile and useful as I used to. 
2 I feel more worthless as compared to other people. 
3 I feel utterly worthless. 
15) Loss of Energy 
0 I have as much energy as ever. 
1 I have less energy than I used to have. 
2 I don't have enough energy to do very much. 
3 I don't have enough energy to do anything. 
16) Changes in Sleeping Pattern 
0 I have not experienced any changes in my sleeping pattern. 
la I sleep somewhat more than usual. 
lb I sleep somewhat less than usual. 
2a I sleep a lot more than usual. 
2b I sleep a lot less than usual. 
3a I sleep most of the day. 
3b I wake up 1-2 hours early and can't get back to sleep. 
17) Irritability 
0 I am no more irritable than usual. 
1 I am more irritable than usual. 
2 I am much more irritable than usual. 
3 I am irritable all the time. 
18) Changes in Appetite 
0 I have not experienced any changes in my appetite. 
la My appetite is somewhat less than usual. 
lb My appetite is somewhat greater than usual. 
2a My appetite is much less than before. 
2b My appetite is much greater than usual. 
3a I have no appetite at all. 
3b I crave food all the time. 
BDT-H 
19) Concentration Difficulty 69 
0 I can concentrate as well as usual. 
1 I can't concentrate as well as usual. 
2 It's hard to keep my mind on anything for very long. 
3 I find I can't concentrate on anything. 
20) Tiredness or Fatigue 
0 I am no more tired or fatigued than usual. 
1 I get more tired or fatigued more easily than usual. 
2 I am too tired or fatigued to do a lot of the things I used to do. 
3 I am too tired or fatigued to do most of the things I used to do. 
21) Loss of Interest in Sex 
0 I have not noticed any recent change in my interest in sex. 
1 I am less interested in sex than I used to be. 
2 I am much less interested in sex now. 
3 I have lost interest in sex completely. 
Page 4 of4 
Copyright © 1996 by Aaron T. Beck. 
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Need to find correct instructions for this measure 
1. Do you think you are more 
liable to illness than other people? , Yes No. 
2. Do you think you worry about your 
health more than most people? Yes .-. .No. 
3. If a disease is brought to your attention (through the 
radio, television, newspapers or someone you 
know) do you worry about getting it yourself? Yes No. 
4. Do you think there is something 
seriously wrong with your body? Yes No. 
5. Are you more sensitive to pain than other people? Yes .No. 
6. Do you get sick easily? Yes No. 
7. Do you often think you might suddenly fall ill? Yes No. 
8. Do you get the feeling people are not 
taking your illness seriously enough? Yes No. 
9. Do you often worry about the possibilty 
that you have got a serious illness? Yes No. 
Robbins, J. M., & Kirmayer, L. J. (1996). Transient and persistent hypochondriacal worry in primary care. 
Psychological Medicine, 26, 575-589. 
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Appendix I 
Worry and Anxiety Questionnaire (WAQ) 
WAQ 
73 
1. What subjects do you worry about most often? 
a ) _ _ d). 
b) e). 
O f)_ 
For the following items, please circle the corresponding number (0-8). 
2. Do your worries seem excessive or exaggerated? 
Not at all Moderately Totally 
excessive excessive excessive 
0 1 2 3 4 5 6 7 8..... 
3. Over the past six months, how many days have you been bothered by excessive worry? 
1 day 
Never out of 2 Everyday 
0 1 2 3 4 5 6.... 7 8..... 
4. Do you have difficulty controlling your worries? For example, when 
you start worrying about something, do you have difficulty stopping? 
No Moderate Extreme 
difficulty difficulty difficulty 
0 1 2 3 4 5 6 7 8 
WAQ Page 2 of2 
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5. Over the past six months, to what extent have you been disturbed by the following sensations 
when you were worried or anxious? Rate each sensation by circling a number (0-8). 
a) Restlessness or feeling keyed up or oh edge. 
Very 
Not at all Moderately severely 
0 1 2 3 4 5 6 7 8...... 
b) Being easily fatigued. 
Very 
Not at all Moderately severely 
0 1 2 3 4...... 5 6 7 8...... 
c) Difficulty concentrating or mind going blank. 
Very 
Not at all Moderately severely 
0 1 2 3 4 5 6 ..7... 8 
d) Irritability. 
Very 
Not at all Moderately severely 
0 .1 2 3 4 5 6.... 7 8...... 
e) Muscle tension. 
Very 
Not at all Moderately severely 
0 1 2 ...3 4 5 6 7 8 
f) Sleep disturbance (difficulty falling or staying asleep, or restless unsatisfying sleep). 
Very 
Not at all Moderately severely 
......0 1 2 3 4 5 6. 7 8 
6. To what extent does worry or anxiety interfere with your life? For example, your work, social 
activities, family life, etc.? 
Very 
Not at all Moderately severely 
0 1 2 3.. . 4 5 6 7 8 
Dugas, M. J., Freeston, M. H., Provencher, M. D., Lachance, S., Ladouceur, R., & Gosselin, P. (2001). Journa 
Comportementale et Cognitive, 11(1), 31-36. 
